All types of cancer cells are captured during spin
작성자. External Relations Team
A machine rapidly and robustly separates cancer cells from blood samples, overcoming challenges with currently available techniques.
A new approach developed by DGIST scientists and CTCELLS company teams in Korea can successfully and rapidly isolate rare circulating tumor cells from patient blood samples. The team’s findings, published in the journal Theranostics, could help improve cancer diagnosis and the ability to provide targeted and personalized treatments.
Circulating tumor cells are cells that break off from cancers and are released into the blood stream. They can go on to form the seeds for new tumor formation in other parts of the body, known as metastases. The advantage of isolating them from the blood is that they represent the diversity of cancer cells found in a person’s body and identifying them could lead to more targeted therapies. But current techniques used to do this either miss some types of circulating tumor cells or are done manually, which takes a lot of time and specialized training.
“Our smart and practical approach realizes a big dream in the field of liquid biopsy and demonstrates high performance across a wide range of cell types and different cancers with full automation,” says Minseok S. Kim at the Department of New Biology at Daegu Gyeongbuk Institute of Science & Technology (DGIST).
The fully automated centrifugation approach is called Continuous Centrifugal Microfluidics – Circulating Tumor Cell Disc (CCM-CTCD). It involves placing a tube containing a blood sample in a machine with a spinning disc. The spinning, or centrifugal force, causes the blood to separate into layers containing different components, with the heavier red blood cells dropping to the bottom, lighter cells floating in a middle layer, and plasma settling at the top. After the disc begins to spin, a laser motor starts rotating at the same angular velocity and phase. This crucial step allows a laser to move and open a valve in the blood sample tube while the disc continues to spin, maintaining a thin layer of tumor and white blood cells, which are released into a separate chamber. The chamber contains antibodies that specifically attach to and separate white blood cells from the mixture. This allows the circulating tumor cells in the mixture to flow on their own into a final chamber.
The team was able to go on to identify the different types of tumor cells and confirm by subsequent DNA testing that they represent the full diversity of different types of cells in the blood sample. They also used the technique on blood samples from patients with varying stages of lung cancer and found the number of circulating tumor cells in a sample correlated with the stage of disease progression. Identification of the types of tumor cells also allowed them to modify treatment strategies.
The team is now working on commercializing the technique for clinical use and hope to expand its application to isolate other types of cells, including nerve, stem and immune cells.
In a press release, we generally advice to keep the headline short and interesting so that it will be more appealing to journalists. For this purpose, we suggest to retain the original headline.
For a similar reason to why the headline should be short and interesting, it is better for a press release not to include abbreviations in the summary as a reader won’t understand what it is and it can distract the reader from continue reading the story.
We suggest not to include this abbreviations as it is not clear to a general audience what it is.
As this is only mentioned once, there is no need for the abbreviation here.
For more information, contact:
Kim, Minseok S.
Department of New Biology
Daegu Gyeongbuk Institute of Science and Technology (DGIST)
Research Paper on Theranostics
Hyeong Jung Woo, Seung-Hoon Kim, Hyo Jung Kang, Soo-Hwan Lee,Seung Joon Lee, Jong Man Kim, Ogan Gurel, Soo Yeol Kim, Hye Ran Roh, Jungmin Lee, Yeonsoo Park, Hyun Young Shin, Yong-Il Shin, Sun Min Lee,So Yeon Oh, Young Zoon Kim, Jung-Il Chae, Seoyoung Lee, Min Hee Hong, Byoung Chul Cho, Eun Sook Lee, Klaus Pantel, Hye Ryun Kim and Minseok S. Kim, "Continuous centrifugal microfluidics (CCM) isolates heterogeneous circulating tumor cells via full automation", online published 01 May, 2022.